Clinical and personal relationships between oral contraceptive and hormone replacement therapy use among US women physicians

Menopause

Volumn 10, Issue 2, 2003, Pages 133-141

  Frank, Erica ^a,c   Elon, Lisa ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

^c EMORY UNIVERSITY   (United States)

Author keywords

Hormone replacement therapy; Oral contraceptives

Indexed keywords

ARTICLE; CLINICAL EXAMINATION; CONTINUING EDUCATION; DISEASE ASSOCIATION; FAMILY HISTORY; FEMALE; FEMALE PHYSICIAN; HORMONE SUBSTITUTION; HUMAN; HYSTERECTOMY; MEDICAL EDUCATION; MEDICAL SOCIETY; ORAL CONTRACEPTION; POSTMENOPAUSE; RISK FACTOR; SEXUAL BEHAVIOR; UNITED STATES; ADULT; AGED; BEHAVIOR; COUNSELING; DRUG UTILIZATION; ESTROGEN THERAPY; HEALTH PERSONNEL ATTITUDE; MIDDLE AGED; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; STATISTICS; UTILIZATION REVIEW;

ORAL CONTRACEPTIVE AGENT;

ADULT; AGED; ATTITUDE OF HEALTH PERSONNEL; CONTRACEPTIVES, ORAL; COUNSELING; DRUG UTILIZATION; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; INTENTION; MIDDLE AGED; PHYSICIANS, WOMEN; POSTMENOPAUSE; QUESTIONNAIRES; UNITED STATES;

EID: 0038386033     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042192-200310020-00004     Document Type: Article

References (31)

1. Abma J, Chandra A, Mosher W, Peterson L, Piccinino L, Fertility, family planning, and women's health: new data from the 1995 National Survey of Family Growth. National Center for Health Statistics. Vital Health Stat 1997;23:1-114.
2. Taylor Nelson Research. Incidence and Persistency Study. Horsham, PA: Taylor Nelson Research, 2000.
3. IMS. New Prescription Audit. May 2001.
4. Lehtonen R, Pahkinen EJ. Practical Methods for Design and Analysis of Complex Surveys. New York: John Wiley and Sons, 1996.
5. McNagny SE, Wenger NK, Frank E. Personal use of postmenopausal hormone replacement therapy by women physicians in the United States. Ann Intern Med 1997;127:1093-1096.
6. Frank E. Contraceptive use by female physicians in the United States. Obstet Gynecol 1999;94:666-671.
7. Falik M, Collins K, Women's Health: The Commonwealth Fund Survey. Baltimore: Johns Hopkins University Press, 1996.
8. Keating NL, Cleary PD, Rossi AS, Zaslavsky AM, Ayanian JZ. Use of hormone replacement therapy by postmenopausal women in the United States. Ann Int Med 1999;130:545-553.
9. Phelan EA, Buist DS, Anderson AA, Newton KM, Delaney KM, LaCroix AZ. Understanding attitudes of older women toward hormone replacement therapy. Prev Med 2001;32:49-56.
10. Marsh JV, Brett KM, Miller LC. Racial differences in hormone replacement therapy prescriptions. Obstet Gynecol 1999;93:999-1003.
11. Buist DS, LaCroix AZ, Newton KM, Keenan NL. Are long-term hormone replacement therapy users different from short-term and never users? Am J Epidemiol 1999;149:275-281.
12. Barrett-Connor E. Prevalence, initiation, and continuation of hormone replacement therapy. J Womens Health 1995;4:143-148.
13. Lurie N, Slater J, McGovern P, Ekstrum J, Quam L, Margolis K. Preventive care for women - does the sex of the physician matter? N Engl J Med 1993;329:478-482.
14. Frank E, Rothenberg R, Lewis C, Belodoff BF. Correlates of physicians' prevention-related practices: findings from the Women Physicians' Health Study. Arch Fam Med 2000;9:359-367.
15. Saver BG, Taylor TR, Woods NF, Stevens NG. Physician policies on the use of preventive hormone therapy. Am J Prev Med 1997;13: 358-365.
16. Isaacs AJ, Britton AR, McPherson K. Why do women doctors in the UK take hormone replacement therapy? J Epidemiol Community Health 1997;51:373-377.
17. Fisher WA, Sand M, Lewis W, Boroditsky R, Canadian menopause study-I: understanding women's intentions to utilize hormone replacement therapy. Maturitas 2000;37:1-14.
18. Lomranz J, Becker D, Eyal N, Pines A, Mester R. Attitudes towards hormone replacement therapy among middle-aged women and men. Eu J Obstet Gynecol 2000;93:199-203.
19. Griffiths F. Women's control and choice regarding HRT. Soc Sci Med 1999;49:469-481.
20. Marmoreo J, Brown JB, Batty HR, Cummings S, Powell M. Hormone replacement therapy: determinants of women's decisions. Patient Ed Counseling 1998;33:289-298.
21. Newton KM, LaCroix AZ, Leveille SG, Rutter C, Keenan NL, Anderson LA. Women's beliefs and decisions about hormone replacement therapy. J Womens Health 1997;6:459-465.
22. Gallager TC, Geling O, FitzGibbons J, Aforismo J, Comite F. Are women being counseled about estrogen replacement therapy? Med Care Research Rev 2000;57:72-92.
23. Rolniek SJ, Kopher RA, Compo RB, Kelley ME, DeFor TA. Provider attitudes and self-reported behaviors related to hormone replacement therapy. Menopause 1999;6:257-263.
24. Dunne FP, Sadler GJ, Crampton JA. Hormone replacement therapy: why are general practitioners not prescribing more? Indian J Clin Prac 1998;52:285-288.
25. Newton KM, LaCroix AZ, Leveille SG, Rutter C, Keenan NL, Anderson LA. The physician's role in women's decision making about hormone replacement therapy. Obstet Gynecol 1998;92:580-584.
26. Sherif K. Benefits and risks of oral contraceptives. Am J Obstet Gynecol 1999;180(Suppl):343-348.
27. Skegg DC. Safety and efficacy of fertility-regulating methods: a decade of research. Bull World Health Org 1999;77:713-721.
28. Kovacs GT, Chick P. Hormone replacement therapy at the menopause: the risks and benefits. Aus Fam Phys 1990;19:73-85.
29. Borgelt L, Umland E. Benefits and challenges of hormone replacement therapy. J Am Phar Assoc 2000;40(Suppl):30-31.
30. Packin GS. Update: the latest on hormone replacement therapy. J Am Osteop Assoc 2000;100(Suppl):2-5.
31. Frank E, Brogan DJ, Mokdad AH, Simoes EJ, Kahn HS, Greenberg RS. Health-related behaviors of women physicians vs other women in the United States. Arch Intern Med 1998;158:342-348.